Zobrazeno 1 - 10
of 2 444
pro vyhledávání: '"direct oral anticoagulant"'
Autor:
Shota Ikeda, Ken‐ichi Hiasa, Hiroshi Inoue, Takeshi Yamashita, Masaharu Akao, Hirotsugu Atarashi, Yukihiro Koretsune, Ken Okumura, Wataru Shimizu, Shinya Suzuki, Takanori Ikeda, Kazunori Toyoda, Atsushi Hirayama, Masahiro Yasaka, Takenori Yamaguchi, Satoshi Teramukai, Tetsuya Kimura, Yoshiyuki Morishima, Atsushi Takita, Hiroyuki Tsutsui
Publikováno v:
ESC Heart Failure, Vol 11, Iss 2, Pp 902-913 (2024)
Abstract Aims Atrial fibrillation (AF) and heart failure (HF) often coexist. Older age is strongly associated with stroke, HF, and mortality. The association between coexistence of HF and a risk of clinical outcomes and the effectiveness of anticoagu
Externí odkaz:
https://doaj.org/article/0a754050a79a45b19691e9ce048af2b0
Autor:
Shin‐Yi Lin, Yen‐Heng Lin, Chih‐Hao Chen, Chung‐Wei Lee, Yuan‐Chang Chao, Yu‐Fong Peng, Ching‐Hua Kuo, Chih‐Fen Huang, Sung‐Chun Tang, Jiann‐Shing Jeng
Publikováno v:
Stroke: Vascular and Interventional Neurology, Vol 4, Iss 5 (2024)
Background In direct oral anticoagulant (DOAC) users with stroke due to large artery occlusion, endovascular thrombectomy is an effective treatment when intravenous thrombolytic therapy is unsuitable. The purpose of this study is to investigate the a
Externí odkaz:
https://doaj.org/article/d891b2fd68274bcea6fe68a177dc0692
Autor:
Nicholas L.J. Chornenki, Heather McPhaden, Erica A. Peterson, Chieh Min Benjamin Lai, Agnes Y.Y. Lee
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 8, Iss 6, Pp 102546- (2024)
Background: While anticoagulation therapy is highly effective at treating venous thromboembolism, some patients can develop rapidly progressive thrombosis in multiple organs or sites despite therapeutic anticoagulation. Effective strategies to manage
Externí odkaz:
https://doaj.org/article/78aa9eecd1e443eab9758105e4ced1e4
Publikováno v:
Heliyon, Vol 10, Iss 16, Pp e36222- (2024)
Background: Hip fractures primarily occur in older people and represent a significant public health issue due to their high incidence and mortality rate. The concurrent occurrence of venous thromboembolism (VTE) during the perioperative period exacer
Externí odkaz:
https://doaj.org/article/f7df8127bd6641d4a84ca25225a607bd
Autor:
Kazuhisa Kaneda, Yugo Yamashita, Takeshi Morimoto, Ryuki Chatani, Yuji Nishimoto, Nobutaka Ikeda, Yohei Kobayashi, Satoshi Ikeda, Kitae Kim, Moriaki Inoko, Toru Takase, Shuhei Tsuji, Maki Oi, Takuma Takada, Kazunori Otsui, Jiro Sakamoto, Yoshito Ogihara, Takeshi Inoue, Shunsuke Usami, Po‐Min Chen, Kiyonori Togi, Norimichi Koitabashi, Seiichi Hiramori, Kosuke Doi, Hiroshi Mabuchi, Yoshiaki Tsuyuki, Koichiro Murata, Kensuke Takabayashi, Hisato Nakai, Daisuke Sueta, Wataru Shioyama, Tomohiro Dohke, Ryusuke Nishikawa, Koh Ono, Takeshi Kimura
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 15 (2024)
Background There have been limited data on the changes in clinical outcomes after the introduction of direct oral anticoagulants (DOACs) for venous thromboembolism (VTE) in real clinical practice. We evaluated the changes in management strategies and
Externí odkaz:
https://doaj.org/article/5df8e7cb04aa414a9116a7c9beda522d
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 15 (2024)
Background Direct oral anticoagulants (DOACs) have been the drug of choice for preventing ischemic stroke in patients with atrial fibrillation since 2014. In previous studies, the stroke risk while taking warfarin was 2 per 100 patient‐years and 1.
Externí odkaz:
https://doaj.org/article/5a348a7709fa4f44abe95c5fa65861de
Autor:
Theresa Frank, Jens Neumann, Anne Assmann, Stefanie Schreiber, Aiden Haghikia, Maria Barleben, Michael Sailer, Michael Goertler
Publikováno v:
Cerebrovascular Diseases Extra, Vol 14, Iss 1, Pp 21-29 (2024)
Introduction: Non-adherence to recommended secondary preventive anticoagulation in stroke patients with atrial fibrillation (AF) is a common phenomenon, although the introduction of direct oral anticoagulants (DOACs) has simplified anticoagulation ma
Externí odkaz:
https://doaj.org/article/c4ccd5c679d9480aaae64b73f51adc8e
Autor:
Mika Lehto, Alex Luojus, Olli Halminen, Jari Haukka, Jukka Putaala, Miika Linna, Pirjo Mustonen, Janne Kinnunen, Ossi Lehtonen, Konsta Teppo, Paula Tiili, Elis Kouki, Saga Itäinen-Strömberg, Mikko Niemi, Aapo L. Aro, Juha Hartikainen, K. E. Juhani Airaksinen
Publikováno v:
Annals of Medicine, Vol 56, Iss 1 (2024)
Background Little is known how individual time-in-therapeutic-range (TTR) impacts the effectiveness and safety of warfarin therapy compared to direct oral anticoagulants (DOACs) in patients with atrial fibrillation (AF).Objective To compare the effec
Externí odkaz:
https://doaj.org/article/73fe543e868b49939f16146669005f27
Autor:
Tasuku Nakabori, Kei Kunimasa, Masaki Kawabata, Sena Higashi, Kaori Mukai, Takahisa Kawamura, Takako Inoue, Motohiro Tamiya, Kazumi Nishino, Kazuyoshi Ohkawa
Publikováno v:
Cancer Medicine, Vol 13, Iss 12, Pp n/a-n/a (2024)
Abstract Aim Atezolizumab and bevacizumab (Atezo/Bev) combination immunotherapy regimens and direct oral anticoagulants (DOACs) are both associated with bleeding. Therefore, combining Atezo/Bev regimens with DOACs may exacerbate the bleeding risk. Th
Externí odkaz:
https://doaj.org/article/6133491ea5814b7aa992d3c06c4daae2
Autor:
Lauren Shitanishi, PharmD, Ashley Fan, PharmD, Tam Khuu, PharmD, Darko Vucicevic, MD, Megan Kamath, MD, Jeffrey J. Hsu, MD, PhD, Alexandra Klomhaus, PhD, Reza Ardehali, MD, PhD
Publikováno v:
JHLT Open, Vol 4, Iss , Pp 100061- (2024)
Background: Direct oral anticoagulants (DOACs) have transformed the field of anticoagulation, offering more predictable pharmacokinetic and pharmacodynamic characteristics when compared to traditional warfarin therapy. DOAC use in the heart transplan
Externí odkaz:
https://doaj.org/article/236b168ab3c64eabba0321279b24a563